Expertise in
12
conditions

Dr. Donald E. Macfarlane

Hematology | Oncology
University Of Iowa Stead Family Children's Hospital
200 Hawkins Dr, 
Iowa City, IA 
Accepting New Patients
Expertise in
12
conditions
University Of Iowa Stead Family Children's Hospital
200 Hawkins Dr, 
Iowa City, IA 

Overview

Donald Macfarlane is a Hematologist and an Oncologist practicing medicine in Iowa City, Iowa.

Dr. Macfarlane is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Familial Pancreatic Cancer, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 2 clinical trials. Dr. Macfarlane is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in IA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Sanford Health
  • HMO
  • PPO
Wellmark
  • HMO
  • POS

Locations

University of Iowa Stead Family Children's Hospital
200 Hawkins Dr, Iowa City, IA 52242

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2b, Open-Label, Single-Arm Study of Selinexor (KPT-330) Plus Low-Dose Dexamethasone (Sd) in Patients With Multiple Myeloma Previously Treated With Lenalidomide, Pomalidomide, Bortezomib, Carfilzomib, and an Anti-CD38 Monoclonal Antibody (mAb) Daratumumab, and Refractory to Prior Treatment With Glucocorticoids, an Immunomodulatory Agent, a Proteasome Inhibitor, and an the Anti-CD38 mAb Daratumumab
A Phase 2b, Open-Label, Single-Arm Study of Selinexor (KPT-330) Plus Low-Dose Dexamethasone (Sd) in Patients With Multiple Myeloma Previously Treated With Lenalidomide, Pomalidomide, Bortezomib, Carfilzomib, and an Anti-CD38 Monoclonal Antibody (mAb) Daratumumab, and Refractory to Prior Treatment With Glucocorticoids, an Immunomodulatory Agent, a Proteasome Inhibitor, and an the Anti-CD38 mAb Daratumumab
Enrollment Status: Completed
Publish Date: January 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
An Open Label, Multicenter, Phase II Trial Testing Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
An Open Label, Multicenter, Phase II Trial Testing Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
Enrollment Status: Terminated
Publish Date: June 02, 2022
Intervention Type: Procedure, Drug
Study Drug: Decitabine
Study Phase: Phase 2
View 1 Less Clinical Trial

6 Total Publications

The hope and the hype of artificial intelligence for syncope management.
The hope and the hype of artificial intelligence for syncope management.
Journal: European heart journal. Digital health
Published: January 06, 2025
Similar Doctors
Expertise in
16
conditions
Dr. Daniel J. Berg
Hematology | Oncology
Expertise in
16
conditions
Dr. Daniel J. Berg
Hematology | Oncology
Referral may be required

University Of Iowa Stead Family Children's Hospital

200 Hawkins Dr, 
Iowa City, IA 
 (0.1 miles away)
319-353-7800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Daniel Berg is a Hematologist and an Oncologist practicing medicine in Iowa City, Iowa. Dr. Berg is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Berg is currently accepting new patients.

Expertise in
6
conditions
Dr. Guido J. Tricot
Hematology | Oncology
Expertise in
6
conditions
Dr. Guido J. Tricot
Hematology | Oncology
Referral may be required

University Of Iowa Stead Family Children's Hospital

200 Hawkins Dr, 
Iowa City, IA 
 (0.1 miles away)
319-356-2148
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Guido Tricot is a Hematologist and an Oncologist practicing medicine in Iowa City, Iowa. Dr. Tricot is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, and Bone Marrow Transplant. Dr. Tricot is currently accepting new patients.

Expertise in
14
conditions
Dr. Thomas H. Carter
Hematology | Oncology
Expertise in
14
conditions
Dr. Thomas H. Carter
Hematology | Oncology
Referral may be required

University Of Iowa Stead Family Children's Hospital

200 Hawkins Dr, 
Iowa City, IA 
 (0.1 miles away)
319-356-0489
Languages Spoken:
English
See accepted insurances

Thomas Carter is a Hematologist and an Oncologist practicing medicine in Iowa City, Iowa. Dr. Carter is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Acute Monoblastic Leukemia (AmoL), Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), and Acute Myeloblastic Leukemia without Maturation.

Frequently Asked Questions about Dr. Donald E. Macfarlane

How do I make an appointment with Dr. Donald E. Macfarlane?

You can book an appointment with Dr. Donald E. Macfarlane by calling their office at 319-356-2527. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Donald E. Macfarlane a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Donald E. Macfarlane is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Donald E. Macfarlane specialize in?

While Dr. Donald E. Macfarlane is a Hematology, they have specific expertise in Multiple Myeloma, Acute Myeloid Leukemia (AML), and Acute Myeloblastic Leukemia without Maturation. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Donald E. Macfarlane participate in research or clinical trials?

Yes. Dr. Donald E. Macfarlane has published 6 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Donald E. Macfarlane's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Donald E. Macfarlane accept my insurance?

Dr. Donald E. Macfarlane accepts most major insurance plans, including Blue Cross Blue Shield and Medica. We recommend calling the office directly at 319-356-2527 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Macfarlane's expertise for a condition
ConditionClose
      View All 12 Advanced Conditions
      View All 56 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile